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Increased dietary oxalate does not increase urinary calcium Idiopathic hypercalciuria is common in patients with
oxalate saturation in hypercalciuric rats. nephrolithiasis and raises urinary supersaturation with
Background. Human calcium oxalate (CaOx) nephrolithia- respect to calcium oxalate (CaOx), the most common
sis may occur if urine is supersaturated with respect to the
solid phase found in renal stones, as well as brushitesolid-phase CaOx. In these patients, dietary oxalate is often
(CaHPO4) [1, 2]. Idiopathic hypercalciuria appears torestricted to reduce its absorption and subsequent excretion
in an effort to lower supersaturation and to decrease stone have a genetic origin, and its pathogenesis involves a
formation. However, dietary oxalate also binds intestinal cal- complex interaction of increased intestinal calcium ab-
cium, which lowers calcium absorption and excretion. The ef- sorption, increased bone resorption, and decreased renal
fect of increasing dietary oxalate on urinary CaOx supersatura-
tubule calcium reabsorption [3, 4].tion is difficult to predict.
Through over 37 generations of successive inbreedingMethods. To determine the effect of dietary oxalate intake
of the most hypercalciuric progeny of hypercalciuricon urinary supersaturation with respect to CaOx and brushite
(CaHPO4), we fed 36th and 37th generation genetic hypercalci- Sprague-Dawley rats, we have established a strain of
uric rats a normal Ca diet (1.2% Ca) alone or with sodium rats, each of which excrete abnormally large amounts of
oxalate added at 0.5%, 1.0%, or 2.0% for a total of 18 weeks. urinary calcium [5–15]. The principal mechanism for the
We measured urinary ion excretion and calculated supersatura-
excessive calcium excretion in these rats appears to betion with respect to the CaOx and CaHPO4 solid phases and
an increase in intestinal calcium absorption [13]. Thedetermined the type of stones formed.
increased intestinal calcium absorption appears to beResults. Increasing dietary oxalate from 0% to 2.0% signifi-
cantly increased urinary oxalate and decreased urinary calcium mediated not by an increase in the serum level of
excretion, the latter presumably due to increased dietary oxa- 1,25(OH)2D3, but by an increase in the number of intesti-
late-binding intestinal calcium. Increasing dietary oxalate from nal vitamin D receptors [12]. When these hypercalciuric0% to 2.0% decreased CaOx supersaturation due to the de-
rats are fed a very low-calcium diet, their urine calciumcrease in urinary calcium offsetting the increase in urinary
excretion remains elevated compared with that of simi-oxalate and the decreased CaHPO4 supersaturation. Each rat
in each group formed stones. Scanning electron microscopy larly treated control rats, indicating a defect in renal
revealed discrete stones and not nephrocalcinosis. X-ray and calcium reabsorption and/or an increase in bone resorp-
electron diffraction and x-ray microanalysis revealed that the tion [11]. The bone from these hypercalciuric rats re-
stones were composed of calcium and phosphate; there were leases more calcium, compared with bone of control rats,no CaOx stones.
when exposed to increasing amounts of 1,25(OH)2D3 [8],Conclusion. Thus, increasing dietary oxalate led to a de-
and inhibition of bone resorption substantially decreasescrease in CaOx and CaHPO4 supersaturation and did not alter
the universal stone formation found in these rats, nor the type the hypercalciuria when these rats are fed a low-calcium
of stones formed. These results suggest the necessity for human diet [14]. In addition, a primary defect in renal calcium
studies aimed at determining the role, if any, of limiting oxalate reabsorption is observed during carefully controlled
intake to prevent recurrence of CaOx nephrolithiasis.
clearance studies [6]. We have shown that both the bone
and kidney of the hypercalciuric rats have an increased
number of vitamin D receptors [8, 12, 15]. Thus, theseKey words: kidney stones, brushite, nephrolithiasis, hypercalciuria,
CaOx, calcium reabsorption, bone resorption, GHS rats. hypercalciuric rats appear to have a systemic abnormality
in calcium homeostasis. They absorb more intestinal cal-Received for publication January 26, 1998
cium. They resorb more bone, and they fail to reabsorband in revised form August 24, 1998
Accepted for publication August 25, 1998 filtered calcium adequately. As each of these hypercalci-
uric rats forms renal stones, we have termed the rats 1999 by the International Society of Nephrology
602
Bushinsky et al: Effects of dietary oxalate on urinary CaOx saturation 603
genetic hypercalciuric stone-forming (GHS) rats [7, 9]. diet for a total of 18 weeks. Rats were offered 15 g/day
of the diet that we have previously shown is the amountCalcium transport abnormalities similar to those docu-
mented in the GHS rats have been observed in patients of food consumed by a female rat of this weight [26–28].
Rats were fed either this diet alone or with sodium oxa-with idiopathic hypercalciuria [16].
Therapy for patients with idiopathic hypercalciuria late added as 0.5%, 1.0%, or 2.0% for a total of 18
weeks. Every two weeks, two successive 24-hour urineand CaOx nephrolithiasis may include restriction of di-
etary oxalate, even though their urinary oxalate excre- collections were obtained. The first 24-hour urine was
collected in thymol and was used for all measurementstion is often no greater than that found in non–stone-
forming people [1, 16, 17]. Oxalate restriction is used to except oxalate, and the second 24-hour urine was col-
lected in concentrated HCl for measurement of oxalate.reduce intestinal oxalate available for absorption, which
should lead to a decrease in urinary oxalate excretion Both samples were frozen at 2708C, and biochemical
measurements were determined within two weeks. At[18–20]. However, dietary oxalate also binds intestinal
calcium so that a reduction in oxalate will increase the the conclusion of the experiment (18 weeks), each rat
was killed, and the entire urinary tract was examined,available, unbound calcium for absorption [17, 21–25].
Because of the complex interaction between intestinal by direct vision, for stones. The kidneys, ureters, and
bladder were dissected in block and mounted on radio-calcium and oxalate and the subsequent absorption of
each of these ions, a reduction in dietary oxalate could graphic film. Any stone found was analyzed for crystal
type and composition. Any rat that ate less than 12 g ofpotentially reduce, not change, or even increase urinary
CaOx supersaturation. food or drank less than 15 ml of water on any day of
the study would have been excluded from the entireThe purpose of this study was to use the GHS rats to
determine the effect of an increase in dietary oxalate on study; however, all rats met these prospective criteria
throughout the study.urinary calcium excretion and CaOx supersaturation. We
found that increasing dietary oxalate led to a decrease
Chemical determinationsin CaOx supersaturation and did not alter the universal
stone formation found in these GHS rats, nor the type of Calcium was measured by reaction with arsenazo III
and then determined photometrically at 650 nm [29].stones formed. Thus, reducing dietary oxalate in patients
with CaOx nephrolithiasis may not appear warranted if Creatinine was determined by a modification of the Jaffe
method by formation of a creatinine-picrate complexthese results, observed in the GHS rat, can be applied
to humans. [30]. Inorganic phosphorus was measured by reaction
with ammonium molybdate to form a colored phospho-
molybdate complex [31]. Uric acid was measured after
METHODS
oxidation by uricase to produce allantoin and hydrogen
Establishment of hypercalciuric rats peroxide [32]. Magnesium was determined by combina-
tion with calmagite [33]. Ammonia was determined byInitially, 20 male and 20 female adult Sprague-Dawley
rats (Charles River Laboratories, Kingston, NY, USA) coupled enzyme system using glutamate dehydrogenase
and nicotinamide adenine dinucleotide phosphate [34].were screened for hypercalciuria. The rats were placed
in individual metabolic cages and were allowed five days Sodium was determined by a selective electrode [35] and
potassium using a valinomycine membrane attached toto adjust to the cage and diet. During this time, the
animals were fed 13 g/day of a diet containing 1.2% a potassium electrode [36]. Chloride was measured by
colorimetry using a silver/silver chloride electrode [37].calcium, 0.90% phosphorus, 0.24% magnesium, 0.40%
sodium, and 0.43% potassium, as well as 2.2 IU vitamin Oxalic acid was measured using oxalate oxidase, which
oxidizes oxalate to hydrogen peroxide and carbon diox-D3/g of food. Deionized distilled water was provided ad
libitum. Two successive 24-hour urine collections in 0.25 ide. The hydrogen peroxide then reacts with 3-methyl-2-
benzothiazolinone hydrozone and 3-(dimethyl)benzoicml 12 n HCl were then obtained on days 6 and 7 to
measure urine calcium excretion. The three male and acid to form an indamine dye [38]. Citric acid was deter-
mined using citrate lyase, which catalyzes the conversionthree female rats with the greatest calcium excretion
were used to breed the next generation. A similar proto- citrate to oxaloacetic acid, which is then converted to
malic acid, in the presence of malate dehydrogenase.col was used to select the two to three most hypercalciuric
males and the three to four most hypercalciuric females The malic acid oxidizes NADH to NAD1 [39]. pH was
measured by an ion-selective electrode.for inbreeding of subsequent generations [5, 6, 8–15].
Study protocol Urinary supersaturation
The CaOx ion activity product was calculated usingTwenty 36th and twelve 37th generations of female GHS
rats, for a total of 32 rats, each weighing 150 g, were the computer program EQUIL, developed by Finlayson
and Brown et al [40–42]. The computer program calcu-kept in the metabolic cages and continued on the same
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lates free-ion concentrations using the concentrations California, Los Angeles, CA, USA) on a digital com-
puter. A P , 0.05 was considered significant.of measured ligands and known stability constants. Ion
activity coefficients are calculated from ionic strength
using the Davies modification of the Debye-Huckel solu-
RESULTS
tion to the Poisson-Boltzman equation. The program
Urinary ion excretionsimultaneously solves for all known binding interactions
among the measured substances. Oxalate, phosphorus, Every two weeks, two successive 24-hour urine collec-
tions were obtained. The individual urine collections forand calcium ion activities were used to calculate the
free-ion activity products. The free ions in solution are the 32 rats divided equally into four groups were ana-
lyzed separately and were then averaged over the firstconsidered to be in an equilibrium with the dissolved
CaOx governed by a stability constant (K) of 2.746 3 six weeks, the second six weeks, and the final six weeks.
With respect to urinary oxalate, over the first six103 m21 and with the dissolved CaHPO4 governed by a
K of 0.685 3 103 m21. The value of CaOx in a solution weeks, there was an increase in oxalate excretion with
the addition of 1.0% and 2.0% dietary oxalate comparedat equilibrium with a solid phase of CaOx, the solubility
of CaOx, is 6.16 3 1026 m per liter. The value of the with control and 0.5% oxalate; rats receiving 2.0% oxa-
late excreted more oxalate than rats receiving 1.0% oxa-CaHPO4 in a solution at equilibrium with a solid phase
of CaHPO4, the solubility of CaHPO4, is 3.981 3 1027 late (Fig. 1A). During the second six weeks, there was
an increase in oxalate excretion with 0.5%, 1.0%, andm per liter. The relative supersaturation for CaOx is
calculated as the ratio of the free-ion activity product of 2.0% oxalate compared with controls; rats receiving
1.0% and 2.0% oxalate excreted more oxalate than ratscalcium and oxalate in the individual urine to the solubil-
ity of CaOx. The relative supersaturation for CaHPO4 receiving 0.5% oxalate. During the final six weeks, there
was an increase in oxalate excretion with 0.5%, 1.0%,is calculated as the ratio of the free-ion activity product
of calcium and phosphate in the individual urine to the and 2.0% oxalate compared with controls. Thus, com-
pared with controls, at all time periods, urinary oxalatesolubility of calcium phosphate. Ratios of one connote
a sample at equilibrium, above one supersaturation, and excretion was increased with 1.0% and 2.0% dietary
oxalate and in the latter two time periods with 0.5%,below one undersaturation.
The ability of this computer program to accurately 1.0%, and 2.0% dietary oxalate.
With respect to urinary calcium, over the first six weekspredict the saturation of urine or other solution with
respect to the solid phase is excellent [10, 11, 40, 43, 44]. there was a decrease in calcium excretion with the addi-
tion of 2.0% oxalate compared with controls, 0.5% andWith a series of 20 artificial solutions, the equilibrium
calcium concentration and the extent of calcium precipi- 1.0% oxalate (Fig. 1B). Over the second six weeks, there
was a decrease in urinary calcium with the addition oftation were predicted with average errors of 5% 6 9%
and 5 6 8% (mean 6 sd), respectively [40]. We have used 0.5%, 1.0%, and 2.0% oxalate compared with controls.
Over the third six weeks, there was a decrease in urinarythis computer program previously and found excellent
correspondence between calculated and experimentally calcium with 0.5%, 1.0%, and 2.0% oxalate compared
with controls; 2.0% oxalate was lower than all othermeasured saturations in urine and blood [5, 9–11] and
in bone culture medium [43–45]. groups.
With respect to urinary phosphorus, over the first six
Transmission electron microscopy, x-ray microanalysis, weeks there was an increase in urinary phosphorus with
and electron diffraction 2.0% oxalate compared with controls, 0.5% and 1.0%
oxalate (Fig. 1C). Over both the second and third sixSmall pieces of the stones were placed in Beem cap-
sules and were embedded in Spurr epoxy resin without weeks, there was an increase in urinary phosphorus with
1.0% oxalate compared with controls and with 2.0%any chemical fixation or dehydration. The blocks were
cut on a Sorval MT6000 microtome with a diamond knife. oxalate compared with controls, 0.5% and 1.0% oxalate.
With respect to urinary sodium, over the first six weeksTwo hundred nm sections were placed on carbon-coated
formvar grids for microanalysis and selected area elec- there was an increase in sodium excretion with 1.0% and
2.0% oxalate compared with controls and with 2.0%tron diffraction. Microscopy was carried out on a Phillips
EM430 equipped with an Oxford Instruments AN10000 oxalate compared with 0.5% and 1.0% oxalate (Fig. 2A).
Over the second six weeks, there was an increase inmicroanalysis system.
sodium excretion with 0.5%, 1.0%, and 2.0% oxalate
Statistical analysis compared with controls, and with 2.0% oxalate com-
pared with 0.5% and 1.0% oxalate. Over the third sixAll values are expressed as mean 6 se. Tests of signifi-
cance were calculated by analysis of variance with the weeks, there was an increase in sodium excretion with
both 1.0% and 2.0% oxalate compared with controls andBonferroni correction for multiple comparisons using
conventional computer programs (BMDP; University of 0.5% oxalate.
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Fig. 1. Urine oxalate, calcium, and phosphorus ex-
cretion (mean 6 SE) in GHS rats fed 15 g/day of a
1.2% Ca diet alone or with added sodium oxalate
at 0.5%, 1.0%, or 2.0% for a total of 18 weeks.
Every two weeks, individual 24-hour urine collec-
tions were obtained. The individual urine collec-
tions for each of the eight rats in the each of the
four groups were analyzed separately and were then
averaged over the first six weeks (weeks 1–6), the
second six weeks (weeks 7–12), and the final six
weeks (weeks 13–18). Abbreviations are: Ctl, GHS
rats fed 15 g/day of the 1.2% Ca diet without added
oxalate; 0.5%, GHS rats fed 15 g/day of the 1.2%
Ca diet with 0.5% sodium oxalate; 1.0%, GHS rats
fed 15 g/day of the 1.2% Ca diet with 1.0% sodium
oxalate; 2.0%, GHS rats fed 15 g/day of the 1.2%
Ca diet with 2.0% sodium oxalate; *, different from
Ctl, P , 0.05; 1, different from 0.5%, P , 0.05.
8, different from 1.0%; P , 0.05.
With respect to urinary magnesium, over the first six with 2.0% oxalate compared with 1.0% oxalate, and over
the third six weeks, there was a decrease in magnesiumweeks there was no change in magnesium excretion with
the addition of oxalate (Fig. 2B). Over the second six excretion with 2.0% oxalate compared with controls.
With respect to urinary pH, over the first six weeksweeks, there was an increase in magnesium excretion
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Fig. 2. Urine sodium and magnesium excretion
and urine pH (mean 6 SE) in GHS rats fed 15 g/
day of a 1.2% Ca diet alone or with added sodium
oxalate at 0.5%, 1.0%, or 2.0% for a total of 18
weeks. Abbreviations are the same as in Figure 1.
there was an increase in urinary pH with 2.0% oxalate with controls, an increase with 1.0% compared with 0.5%
and with 2.0% compared with 0.5% and 1.0% oxalate.compared with controls and 0.5% oxalate (Fig. 2B). Over
the second six weeks, there was an increase in urinary Over the final six weeks, there was an increase in urine
pH with 0.5%, 1.0%, and 1.5% dietary oxalate comparedpH with 0.5%, 1.0%, and 2.0% dietary oxalate compared
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Fig. 3. Urine volume and creatine excretion
(mean 6 SE) in GHS rats fed 15 g/day of a 1.2%
Ca diet alone or with added sodium oxalate at
0.5%, 1.0%, or 2.0% for a total of 18 weeks.
Abbreviations are the same as in Figure 1.
with controls, and an increase with 2.0% dietary oxalate ing 2% oxalate compared with the controls. There was
no difference in urinary citrate between any other groupcompared with 0.5% and 1.0% oxalate.
at any other time period of the study (data not shown).With respect to urinary volume, over the first six weeks
During the second and third periods, urinary uric acidthere was no difference in urinary volume in any group
was lower in all of the groups receiving oxalate compared(Fig. 3A). Over the second six weeks, there was an in-
with controls. There was no difference in urinary uriccrease in urinary volume with 1.0% and 2.0% oxalate
acid between any other group at any other time periodcompared with controls and with 2.0% oxalate compared
of the study (data not shown).with 1.0% oxalate. Over the third six weeks, there was an
increase in urinary volume with 2.0% oxalate compared
Urinary supersaturationwith controls. With respect to urinary creatinine, there
was no difference in urinary creatinine in any group Using the individual ion concentrations, the urinary
supersaturation with respect to CaOx and CaHPO4 forduring the entire study (Fig. 3B).
There was no difference in urinary potassium in any each of the rats in the each of the groups was calculated
separately and was then averaged over the first six weeks,group during any time period of the study (data not
shown). Over the second six-week period, urinary ammo- the second six weeks, and the final six weeks.
With respect to CaOx supersaturation, over the firstnium was increased in the group receiving 2% oxalate
compared with the controls and the group receiving 0.5% six weeks, there was no change in supersaturation with
the addition of oxalate (Fig. 4A). Over the second sixoxalate; there was no difference in urinary ammonium
between any other group at any other time period of weeks, there was a decrease in CaOx supersaturation
with 2.0% dietary oxalate compared with controls, 0.5%the study (data not shown). Over the second six-week
period, urinary citrate was increased in the group receiv- and 1.0% dietary oxalate. Over the final six weeks, there
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Fig. 4. Relative saturation ratio of calcium oxa-
late (CaOx) and brushite (CaHPO4) in GHS rats
fed 15 g/day of a 1.2% Ca diet alone or with added
sodium oxalate at 0.5%, 1.0%, or 2.0% for a total
of 18 weeks. Abbreviations are the same as in
Figure 1.
was a decrease in CaOx supersaturation with 2.0% di- DISCUSSION
etary oxalate compared with controls and 1.0% dietary We used a well-characterized animal model of idio-
oxalate. pathic hypercalciuria [5–15] to determine the effect of
With respect to CaHPO4 supersaturation, over the first alterations in dietary oxalate on urinary ion excretion
six weeks, there was a decrease in supersaturation with and supersaturation with respect to the key solid phases
the addition of 2.0% dietary oxalate compared with 0.5% CaOx and calcium hydrogen phosphate (CaHPO4). We
oxalate (Fig. 4B). Over the second six weeks, there was found that increasing dietary oxalate led to an increase
no change in supersaturation with the addition of oxa- in urinary oxalate and phosphate excretion and a fall
late. Over the final six weeks, there was a decrease in in calcium excretion. Increasing dietary oxalate did not
CaHPO4 supersaturation with 2.0% dietary oxalate com- increase urinary CaOx supersaturation; rather, it fell at
pared with controls. the highest level of oxalate studied. Increasing dietary
oxalate did not alter the universal occurrence of calcium
Stone formation and identification phosphate stones observed in these rats.
At the conclusion of the study, 18 weeks, all rats in all Increasing dietary oxalate intake led to an increase in
groups were found to have formed stones. We observed urine oxalate excretion. In rats, oxalate is absorbed by
solitary stones, multiple stones, and ureteral stones (Fig. a nonsaturable, energy-independent mechanism in the
5). The electron diffraction pattern of several representa- duodenum, jejunum, ilium, and colon [46]. Oxalate is an
tive calculi from each of the groups revealed the typical end product of several metabolic pathways, including
diffraction pattern of poorly crystalline apatite in all metabolism of glyoxylate and ascorbic acid [47, 48]. The
cases (Fig. 6). X-ray microanalysis of several representa- quantity of urinary oxalate is the sum of intestinal ab-
tive calculi from each of the groups demonstrated only sorption and endogenous production [16]. The increase
in dietary oxalate intake would presumably not alterthe presence of calcium and phosphorus (Fig. 7).
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Fig. 5. Electron micrograph of a representa-
tive rat stone embedded in Spurr epoxy resin
without any chemical fixation or dehydration,
showing agglomerates of needle-like crystals
of apatite (magnification 313,350).
endogenous oxalate production, but would increase the have increased due to the increased urinary sodium ex-
cretion, or perhaps, the decrease in absorbed calciumquantity of oxalate available for absorption and subse-
quent excretion. might have increased the serum level of parathyroid hor-
mone, resulting in enhanced phosphaturia [51].As dietary oxalate was increased, there was a concomi-
tant fall in urinary calcium. This may be secondary to With increasing dietary oxalate, provided as sodium
oxalate, there was an expected increase in urinary so-increased dietary oxalate binding the constant amount
of dietary calcium, resulting in an unabsorbable solid dium [52]. Increasing urine sodium would increase urine
calcium excretion [53–55]; however, with increasing di-phase of CaOx [21–25]. As dietary oxalate was increased,
there was an increase in urinary phosphorus. As is well etary oxalate, urine calcium excretion actually fell, indi-
cating that the effect of oxalate to bind intestinal calciumknown from clinical nephrology, intestinal calcium binds
with phosphate to prevent its absorption [49, 50]. The was greater than the effect of sodium to increase urinary
calcium excretion. If the oxalate were administered with-binding of intestinal calcium with the increasing amounts
of oxalate would decrease calcium available for phos- out sodium, it is likely that there would have been a
greater fall in urinary calcium, resulting in even lowerphate binding. Thus, as dietary oxalate was increased,
more phosphate should be available for intestinal ab- CaOx supersaturation. With increasing dietary oxalate,
urine pH rose. Perhaps the increase in urinary phospho-sorption, resulting in increased urinary phosphorus excre-
tion. Alternatively, urinary phosphorus excretion could rus bound tubular hydrogen ions, leading to an increase
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Fig. 6. Electron diffraction pattern of the rat kidney stone from Figure 5 showing the characteristic D spacings of apatite.
in titratable acidity so that the protons were excreted at and phosphate without detectable oxalate [9]. Additional
dietary oxalate did not influence the type of stonesa higher urinary pH. Although the presumed mecha-
nisms for the alteration in urinary ions appear to result formed, which is not surprising as there was no increase
in supersaturation with respect to the solid phase offrom well-accepted metabolic interactions, further stud-
ies will be necessary to confirm the precise relationships CaOx and no change in supersaturation with respect to
the solid phase of CaHPO4. However, the supersatura-that alter the absorption and subsequent excretion of
individual ions and ionic complexes when dietary oxalate tion with respect to the CaOx solid phase is far greater
than the supersaturation with respect to the CaHPO4is altered.
With increasing dietary oxalate, the increase in urinary solid phase, which suggests that the GHS rats should
form a CaOx solid phase. However, we have previouslyoxalate was offset by the decrease in urinary calcium so
that there was no increase in CaOx supersaturation. At shown that in the GHS rats, increasing urinary CaOx
supersaturation led to an increase in the formation prod-the highest oxalate intake, the increase in urinary vol-
ume, in concert with the changes in ion excretion, led uct, the saturation at which the solid phase will spontane-
ously precipitate, for this solid phase [5]. We have con-to an actual fall in CaOx supersaturation during the
second and third time periods. Similarly, the increase in firmed these results in humans [56]. Thus, examination
of supersaturation is necessary, but not sufficient, to pre-urinary phosphate induced by the increase in dietary
oxalate was offset by the decrease in urinary calcium so dict the formation of a solid phase.
Humans with idiopathic hypercalciuria who formthat there was no increased supersaturation with respect
to CaHPO4. CaOx stones are often told to limit oxalate intake in an
effort to decrease oxalate excretion and decrease CaOxThe GHS rats uniformly make a poorly crystalline
apatite stone, a solid phase composed only of calcium stone formation [1, 16, 17]. Although there may by intu-
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